Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 94.10 billion as of April 17, 2025. Its market cap has decreased by -13.49% in one year.

Market Cap

94.10B

Enterprise Value

n/a

Revenue

108.14B

Ranking

n/a

PE Ratio

56.35

Stock Price

3,290.00

Market Cap Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 94.10B, an increase of 227.04%. That is a compound annual growth rate of 4.08%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2025	92.86B	-6.42%
Dec 30, 2024	99.22B	-12.77%
Dec 28, 2023	113.76B	-14.20%
Dec 29, 2022	132.58B	-19.22%
Dec 30, 2021	164.12B	-22.93%
Dec 30, 2020	212.94B	47.61%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	33.89T
ALTEOGEN	20.94T
Yuhan	8,636.87B
SK Biopharmaceuticals	8,207.23B
HLB Co., Ltd.	7,214.15B
Peptron	4,195.85B
LigaChem Biosciences	3,856.78B

Market Cap Rankings